• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    1.15 0.00(0.00%) Aug 28, 4:00PM EDT
    |After Hours : 1.22 Up 0.07 (6.09%) Aug 28, 7:28PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingApr 30, 2015Apr 30, 2014Apr 30, 2013
    Total Revenue 26,781   22,401   21,683  
    Cost of Revenue15,593  13,110  12,595  
    Gross Profit 11,188   9,291   9,088  
    Operating Expenses
    Research Development42,996  27,723  24,306  
    Selling General and Administrative18,691  17,274  13,134  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (50,499) (35,706) (28,352)
    Income from Continuing Operations
    Total Other Income/Expenses Net142  349  (1,374)
    Earnings Before Interest And Taxes(50,357)(35,357)(28,030)
    Interest Expense1  5  54  
    Income Before Tax(50,358)(35,362)(28,084)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(50,358)(35,362)(29,780)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (50,358) (35,362) (29,780)
    Preferred Stock And Other Adjustments(3,696)(401) -  
    Net Income Applicable To Common Shares (54,054) (35,763) (29,780)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.